Tea Zeppola
Via Alvaro Del Portillo 21
Rome, 00128, Italy
Rome, 00128, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Movement-Based Interventions in Patients Affected by Bone Metastases: Impact on Physical Function and Functional Autonomy-A Systematic Review.
Journal: Cancers
Published: August 20, 2025
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
Journal: Journal of translational medicine
Published: May 01, 2021
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study.
Journal: JCO precision oncology
Published: October 02, 2020
Denosumab for cancer-related bone loss.
Journal: Expert opinion on biological therapy
Published: August 25, 2020
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?
Journal: Clinical Medicine Insights. Oncology
Published: March 04, 2020
Prognostic and predictive factors in pancreatic cancer.
Journal: Oncotarget
Published: January 19, 2020
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study.
Journal: Oncoimmunology
Published: October 05, 2019
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice.
Journal: Journal of translational medicine
Published: September 24, 2019
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 22, 2019
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable.
Journal: Journal for immunotherapy of cancer
Published: December 04, 2018
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.
Journal: The oncologist
Published: September 22, 2018
Last Updated: 09/26/2026